AUTHOR=Kim Young-Cho , Miller Adam , Lins Livia C. R. F. , Han Sang-Woo , Keiser Megan S. , Boudreau Ryan L. , Davidson Beverly L. , Narayanan Nandakumar S. 

TITLE=RNA Interference of Human α-Synuclein in Mouse

JOURNAL=Frontiers in Neurology

VOLUME=8

YEAR=2017

URL=https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2017.00013

DOI=10.3389/fneur.2017.00013

ISSN=1664-2295

ABSTRACT=<p>α-Synuclein is postulated to play a key role in the pathogenesis of Parkinson’s disease (PD). Aggregates of α-synuclein contribute to neurodegeneration and cell death in humans and in mouse models of PD. Here, we use virally mediated RNA interference to knockdown human α-synuclein in mice. We used an siRNA design algorithm to identify eight siRNA sequences with minimal off-targeting potential. One RNA-interference sequence (miSyn4) showed maximal protein knockdown potential <italic>in vitro</italic>. We then designed AAV vectors expressing miSyn4 and injected them into the mouse substantia nigra. miSyn4 was robustly expressed and did not detectably change dopamine neurons, glial proliferation, or mouse behavior. We then injected AAV2-miSyn4 into Thy1-hSNCA mice over expressing α-synuclein and found decreased human α-synuclein (hSNCA) in both midbrain and cortex. In separate mice, co-injection of AAV2-hSNCA and AAV2-miSyn4 demonstrated decreased hSNCA expression and rescue of hSNCA-mediated behavioral deficits. These data suggest that virally mediated RNA interference can knockdown hSNCA <italic>in vivo</italic>, which could be helpful for future therapies targeting human α-synuclein.</p>